Clinical Trial Update: Assessing Sleep and Circadian Rhythms in Primary Brain Tumors Patients

View source ↗

Summary

The NCI-sponsored clinical trial evaluating sleep and circadian rhythms in patients with primary brain tumors has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Neoplasms

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Sleep Circadian Rhythms, Chronodisruption | Status: COMPLETED